Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The clearance rates of separate and combination therapies of chloroquine and doxycycline on malaria, onchocerciasis
and mixed onchocerciasis-malaria parasitemia in 603 volunteers aged 10-60+ years were investigated for baseline and
post-intervention mean parasite densities (MPD) using skin snip biopsy and smear microscopy techniques between March
2012 and April 2014. Subjects were classified into onchocerciasis (n=100), onchocerciasis+ chloroquine-doxycycline therapy
(n=90), malaria (n=104) and concomitant onchocerciasis-malaria (n=309) groups. Standard treatment with doxycycline
was 200mg daily dose for 6 weeks while that of chloroquine was 1000mg loading dose, followed by 500mg after 6-8 hours,
then 500mg each day for 2 days. Result showed that the clearance rates of chloroquine-doxycycline, chloroquine-only and
doxycycline-only on concomitant onchocerciasis-malaria parasitemia were 100%, 94.12% O. volvulus; 52.97% MP and 100%
O. volvulus; 97.70% MP respectively. Chloroquine was shown to potentiate the microfilaricidal action of doxycycline. Chisquare
(X2) analysis showed that the difference between the clearance rates of combination therapy and chloroquine-only
therapy on concomitant onchocerciasis-malaria parasitemia was statistically significant (P<0.05) while the difference between
the clearance rates of combination therapy and doxycycline-only therapy on mixed parasitemia was not statistically significant
(p>0.05). In conclusion, Chloroquine-doxycycline combination therapy proved effective as a novel therapeutic strategy in the
management of separate and co-infection of malaria and onchocerciasis.